Secondary analysis

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

Eur Heart JPublished

  • Secondary analysis of the PARADIGM-HF randomised trial

Authors' conclusion

In patients with HFrEF, alternative anthropometric measurements showed no evidence for an 'obesity-survival paradox'. Newer indices that do not incorporate weight showed that greater adiposity was clearly associated with a higher risk of HF hospitalization.

Study context

Population
Patients with HFrEF enrolled in a trial comparing ARNI with ACEi
Comparison
Newer anthropometric indices vs body mass index (BMI)
Primary endpoint
Heart failure (HF) hospitalization or CV death

Primary result

As reported in the abstract

Primary outcome (HF hospitalization or CV death) by adiposity
  • Greater adiposity (BMI and waist-to-height ratio) associated with higher risk of the primary outcome; more evident for waist-to-height ratio and persisted after adjustment

Further findings

OutcomeaHR (95% CI)
HF hospitalization, waist-to-height ratio1.39 (1.06–1.81)
All-cause mortality, waist-to-height ratio1.10 (0.87–1.39)

All-cause mortality, BMI ≥25 kg/m² vs normal weight

'Obesity-survival paradox' (lower mortality risk with BMI ≥25 kg/m²) identified but eliminated by adjustment for other prognostic variables

Original publication

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. Eur Heart J. Published 22 March 2023. doi:10.1093/eurheartj/ehad083

Summarised from the published abstract; every number is checked against it